Dr. Terence Ketter obtained his medical degree from the University of Toronto and had internship and residency training in psychiatry at the University of California at San Francisco. He had subsequent fellowship training in brain imaging and psychopharmacology research methods at the Biological Psychiatry Branch of the National Institute of Mental Health in Bethesda, Maryland. He is currently Professor of Psychiatry & Behavioral Sciences and Chief of the Bipolar Disorders Clinic at the Stanford University School of Medicine in Stanford, California. Dr. Ketter's research interests include the use of brain imaging methods such as positron emission tomography (PET), magnetic resonance imaging (MRI), and magnetic resonance spectroscopy (MRS) to better understand the neurobiology of mood disorders and to explore the possibility of using these techniques to more effectively target treatments for patients with bipolar disorders. Dr. Ketter also conducts research in the use of novel medications and combinations of medications in the treatment of bipolar disorders, with an emphasis on the use of anticonvulsants.
In constant demand as a speaker, he presents at numerous national and international conferences and advisory boards, and sits on the review panel of several major scientific journals. Within the University, he serves on the Institutional Review Board, the body responsible for reviewing all new research proposals for scientific soundness, ethical conduct, and protection of human subjects.
Inspired by his clinical work with exceptionally creative individuals, Dr. Ketter has developed a strong interest in the relationship of creativity and mood disorders.
Dr. Wang completed his medical education at Washington University in St. Louis, where his interest in mood disorders began, initially with work in volumetric brain imaging in major depression that, found that depression (duration of illness) may be correlated with brain changes (hippocampal atrophy). He came to Stanford University for his psychiatric residency training, served as Chief Resident, and then completed a research fellowship with Dr. Terence Ketter in the Stanford Bipolar Disorders Clinic on Bipolar Disorders treatment and neuroimaging. Dr. Wang also has had an active clinical practice specializing in Bipolar Disorder patients (particularly suffering Bipolar Depression and mood cycling) and treatment-resistant mood disorders since 1999. He has special interest in clinical research trials that advance our understanding of the biology of and new treatment approaches for Bipolar Disorders. He has published numerous manuscripts on treatment of Bipolar Disorders, covering mood stabilizers, new anticonvulsants, and new antipsychotic medications.
Dr. Miller obtained her medical degree at Columbia University and completed her psychiatric residency training at Stanford University, where she served as a Chief Resident. She subsequently completed postdoctoral research fellowship training in bipolar disorder psychopharmacology, working under the mentorship of Dr. Terence Ketter, with funding from the National Institute of Mental Health and the Mental Illness Research, Education and Clinical Centers (MIRECC) of the Veterans Administration. As part of her postdoctoral research, Dr. Miller conducted clinical and neuroimaging studies investigating the impacts of childhood trauma and genetic factors on individuals with bipolar disorder and unipolar major depressive disorder. She also participated in research exploring the link between creativity and bipolar disorder.
Dr. Miller’s current research focuses on understanding the effectiveness of novel treatment and monitoring strategies for bipolar disorder. She is the principal investigator of two clinical research studies, including a randomized, double-blind, placebo-controlled trial of adjunctive suvorexant for insomnia related to bipolar disorder, and a retrospective naturalistic study of the clinical effectiveness of lurasidone in bipolar disorder patients. Dr. Miller and her colleagues are also investigating the use of actigraphy to monitor daytime and nighttime activity in bipolar disorder patients, and how these objective measures of activity may correlate with (and potentially predict the onset of) subjectively reported bipolar mood symptoms. In addition to these academic efforts, she is involved in launching a new community outreach program, FAIR START, which seeks to provide access to free expert consultation and pharmacological treatment for young adults with bipolar disorder, who lack insurance that Stanford accepts.
Dennis Do received his B.A/B.S in Integrative Biology and Nutritional Science from UC Berkeley. He is currently coordinating the research done at the Bipolar Clinic and is also the liaison for the FAIRSTART program at the clinic.
Left to Right: Dr. Shefali Miller M.D. Dr. Po Wang M.D. Dr. Terence Ketter M.D. Dennis Do BS. Saloni Shah BS
This website and its contents are designed for informational purposes only and must not be substituted for professional care.